vs
STANDARD BIOTOOLS INC.(LAB)与Usio, Inc.(USIO)财务数据对比。点击上方公司名可切换其他公司
Usio, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.1倍($22.2M vs $19.6M),Usio, Inc.净利率更高(-6.7% vs -177.4%,领先170.7%),Usio, Inc.同比增速更快(8.2% vs -11.5%),Usio, Inc.自由现金流更多($1.1M vs $-23.1M),过去两年Usio, Inc.的营收复合增速更高(3.0% vs -12.2%)
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
Usio, Inc.是总部位于美国得克萨斯州圣安东尼奥的金融科技企业,主打综合电子支付服务,业务涵盖ACH交易处理、信用卡与借记卡收单、为软件平台提供支付便利、预付卡发行,同时还经营文件打印邮寄业务。
LAB vs USIO — 直观对比
营收规模更大
USIO
是对方的1.1倍
$19.6M
营收增速更快
USIO
高出19.7%
-11.5%
净利率更高
USIO
高出170.7%
-177.4%
自由现金流更多
USIO
多$24.2M
$-23.1M
两年增速更快
USIO
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $19.6M | $22.2M |
| 净利润 | $-34.7M | $-1.5M |
| 毛利率 | 48.5% | 21.9% |
| 营业利润率 | -168.5% | -5.7% |
| 净利率 | -177.4% | -6.7% |
| 营收同比 | -11.5% | 8.2% |
| 净利润同比 | -28.8% | -337.8% |
| 每股收益(稀释后) | $-0.09 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LAB
USIO
| Q4 25 | — | $22.2M | ||
| Q3 25 | $19.6M | $21.2M | ||
| Q2 25 | $21.8M | $20.0M | ||
| Q1 25 | $40.8M | $22.0M | ||
| Q4 24 | — | $20.6M | ||
| Q3 24 | $22.1M | $21.3M | ||
| Q2 24 | $22.5M | $20.1M | ||
| Q1 24 | $45.5M | $21.0M |
净利润
LAB
USIO
| Q4 25 | — | $-1.5M | ||
| Q3 25 | $-34.7M | $-415.1K | ||
| Q2 25 | $-33.5M | $-366.7K | ||
| Q1 25 | $-26.0M | $-235.0K | ||
| Q4 24 | — | $628.9K | ||
| Q3 24 | $-26.9M | $2.9M | ||
| Q2 24 | $-45.7M | $75.5K | ||
| Q1 24 | $-32.2M | $-250.2K |
毛利率
LAB
USIO
| Q4 25 | — | 21.9% | ||
| Q3 25 | 48.5% | 23.0% | ||
| Q2 25 | 48.8% | 25.8% | ||
| Q1 25 | 48.4% | 21.9% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | 54.9% | 23.0% | ||
| Q2 24 | 46.1% | 23.9% | ||
| Q1 24 | 53.1% | 23.1% |
营业利润率
LAB
USIO
| Q4 25 | — | -5.7% | ||
| Q3 25 | -168.5% | -2.2% | ||
| Q2 25 | -118.1% | -2.0% | ||
| Q1 25 | -80.8% | -1.1% | ||
| Q4 24 | — | -2.9% | ||
| Q3 24 | -120.9% | -1.8% | ||
| Q2 24 | -134.5% | -1.0% | ||
| Q1 24 | -132.2% | -1.3% |
净利率
LAB
USIO
| Q4 25 | — | -6.7% | ||
| Q3 25 | -177.4% | -2.0% | ||
| Q2 25 | -153.7% | -1.8% | ||
| Q1 25 | -63.8% | -1.1% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | -122.0% | 13.4% | ||
| Q2 24 | -203.3% | 0.4% | ||
| Q1 24 | -70.6% | -1.2% |
每股收益(稀释后)
LAB
USIO
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $-0.09 | $-0.02 | ||
| Q2 25 | $-0.09 | $-0.01 | ||
| Q1 25 | $-0.07 | $-0.01 | ||
| Q4 24 | — | $0.03 | ||
| Q3 24 | $-0.07 | $0.10 | ||
| Q2 24 | $-0.12 | $0.00 | ||
| Q1 24 | $-0.27 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $7.4M |
| 总债务越低越好 | — | $1.4M |
| 股东权益账面价值 | $399.7M | $17.9M |
| 总资产 | $539.6M | $134.9M |
| 负债/权益比越低杠杆越低 | — | 0.08× |
8季度趋势,按日历期对齐
现金及短期投资
LAB
USIO
| Q4 25 | — | $7.4M | ||
| Q3 25 | $129.4M | $7.7M | ||
| Q2 25 | $158.6M | $8.1M | ||
| Q1 25 | $150.9M | $8.7M | ||
| Q4 24 | — | $8.1M | ||
| Q3 24 | $210.6M | $8.4M | ||
| Q2 24 | $269.8M | $7.2M | ||
| Q1 24 | $287.1M | $7.1M |
总债务
LAB
USIO
| Q4 25 | — | $1.4M | ||
| Q3 25 | — | $836.7K | ||
| Q2 25 | — | $647.1K | ||
| Q1 25 | — | $683.3K | ||
| Q4 24 | — | $719.4K | ||
| Q3 24 | $55.2M | $562.9K | ||
| Q2 24 | $55.1M | $597.2K | ||
| Q1 24 | $55.0M | $630.9K |
股东权益
LAB
USIO
| Q4 25 | — | $17.9M | ||
| Q3 25 | $399.7M | $18.7M | ||
| Q2 25 | $424.5M | $18.7M | ||
| Q1 25 | $454.6M | $19.0M | ||
| Q4 24 | — | $19.2M | ||
| Q3 24 | $489.3M | $18.9M | ||
| Q2 24 | $510.3M | $15.7M | ||
| Q1 24 | $577.3M | $15.3M |
总资产
LAB
USIO
| Q4 25 | — | $134.9M | ||
| Q3 25 | $539.6M | $99.4M | ||
| Q2 25 | $557.0M | $108.4M | ||
| Q1 25 | $579.6M | $109.6M | ||
| Q4 24 | — | $107.2M | ||
| Q3 24 | $681.5M | $114.6M | ||
| Q2 24 | $708.7M | $108.8M | ||
| Q1 24 | $777.7M | $99.1M |
负债/权益比
LAB
USIO
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.04× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | 0.11× | 0.03× | ||
| Q2 24 | 0.11× | 0.04× | ||
| Q1 24 | 0.10× | 0.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $1.5M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $1.1M |
| 自由现金流率自由现金流/营收 | -118.1% | 4.8% |
| 资本支出强度资本支出/营收 | 4.5% | 2.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $1.7M |
8季度趋势,按日历期对齐
经营现金流
LAB
USIO
| Q4 25 | — | $1.5M | ||
| Q3 25 | $-22.2M | $303.8K | ||
| Q2 25 | $-20.7M | $-263.9K | ||
| Q1 25 | $-30.3M | $1.4M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | $-27.9M | $1.4M | ||
| Q2 24 | $-39.0M | $369.1K | ||
| Q1 24 | $-62.5M | $88.7K |
自由现金流
LAB
USIO
| Q4 25 | — | $1.1M | ||
| Q3 25 | $-23.1M | $85.2K | ||
| Q2 25 | $-22.6M | $-503.2K | ||
| Q1 25 | $-35.3M | $1.1M | ||
| Q4 24 | — | $2.7M | ||
| Q3 24 | $-30.1M | $1.4M | ||
| Q2 24 | $-41.0M | $246.3K | ||
| Q1 24 | $-63.3M | $-88.1K |
自由现金流率
LAB
USIO
| Q4 25 | — | 4.8% | ||
| Q3 25 | -118.1% | 0.4% | ||
| Q2 25 | -103.6% | -2.5% | ||
| Q1 25 | -86.6% | 4.8% | ||
| Q4 24 | — | 13.1% | ||
| Q3 24 | -136.4% | 6.4% | ||
| Q2 24 | -182.2% | 1.2% | ||
| Q1 24 | -138.9% | -0.4% |
资本支出强度
LAB
USIO
| Q4 25 | — | 2.0% | ||
| Q3 25 | 4.5% | 1.0% | ||
| Q2 25 | 8.7% | 1.2% | ||
| Q1 25 | 12.4% | 1.4% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | 10.2% | 0.3% | ||
| Q2 24 | 8.6% | 0.6% | ||
| Q1 24 | 1.7% | 0.8% |
现金转化率
LAB
USIO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.61× | ||
| Q3 24 | — | 0.50× | ||
| Q2 24 | — | 4.89× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
USIO
| Credit Card Revenue | $7.7M | 35% |
| ACH And Complementary Service Revenue | $6.1M | 28% |
| Output Solutions | $5.4M | 24% |
| Prepaid Card Services Revenue | $2.6M | 12% |